Bicycle Therapeutics - ADR Financials

$3.83

$-0.18 (-4.37%)

As on 10-Sep-2026 16:14EDT

Market cap

$301 Mln

Revenue (TTM)

$61 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	61.21	72.59	35.28	26.98	14.46	11.70
Cost of Revenue	35.06	6.44	172.97	156.50	3.69	44.88
Gross Profit	61.21	72.59	-137.69	-129.52	14.46	11.70
Operating Expenses	271.56	320.30	72.18	60.43	131.12	77.32
Operating Profit (EBIT)	-210.36	-247.72	-209.87	-189.95	-116.65	-65.62
Other Income	--	--	--	--	--	--
Profit before Tax	-188.68	-218.81	-173.80	-179.21	-114.24	-68.48
Provision for Tax	1.73	0.15	-4.77	1.46	-1.52	-1.66
Profit after Tax (Net Income)	-190.41	-218.96	-169.03	-180.66	-112.72	-66.82
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-112.72	-66.82

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	510.26	609.98	793.06	370.93	270.78	346.25
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	48.69	50.64	96.58	154.88	86.48	97.30
Current Liabilities	47.64	56.98	67.23	69.54	53.34	36.24
Total Liabilities	654.21	717.60	956.87	595.34	410.61	479.79

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	31.34	34.71	28.26	33.48	41.23	21.24
Current Assets	575.24	682.89	928.61	561.87	369.38	458.56
Total Assets	654.21	717.60	956.87	595.34	410.61	479.79
Total Debt*	13.68	17.52	9.49	44.96	44.33	44.34
Net Current Assets	527.60	625.90	861.38	492.33	316.04	422.32

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-249.68	-164.72	-60.63	-86.11	-14.79
Cash Flow from Investing Activities	--	-2.35	-1.24	-2.93	-18.99	-2.03
Cash from Financing Activities	--	-0.13	519.75	250.03	6.69	320.73
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.74	-3.16	-2.45	-4.26	-3.79	-2.32
Cash EPS ($)	--	-3.06	-2.34	-4.10	-3.67	-2.27
Adjusted Book Value ($)	--	8.79	11.49	8.74	9.11	12.03
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.60	-2.39	-1.43	-2.90	-0.51
Free Cash Flow per Share ($)	--	-3.64	-2.40	-1.50	-3.54	-0.58

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-30.62	-27.75	-49.43	-31.94	-26.63
ROE (%)	-34.00	-31.21	-29.04	-56.31	-36.53	-30.25
ROA (%)	-24.35	-26.15	-21.78	-35.92	-25.32	-20.85
EBIT Margin (%)	-307.96	-301.16	-487.79	-652.22	-766.76	-559.96
Net Margin (%)	-311.11	-301.66	-479.18	-669.72	-779.35	-571.25
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	217.44	1.06	0.31	0.87	0.24	0.13
EBIT Growth (%)	26.75	-27.04	2.20	-58.66	-69.31	-26.05
Net Profit Growth (%)	21.43	-29.54	6.44	-60.28	-68.69	-30.99
EPS Growth (%)	21.91	-0.29	0.43	-0.12	-0.63	0.04
Book Value Growth (%)	-24.32	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-2.24	-5.72	-4.25	-7.80	-26.23
Price / Book Value	0.59	0.81	1.22	2.07	3.25	5.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.14	0.56	-0.59	-1.69	-5.45	-21.19
Close Price ($)	4.24	7.08	14.00	18.08	29.60	60.87
High Price ($)	9.18	15.47	28.67	31.91	60.99	62.08
Low Price ($)	3.94	6.03	12.17	12.54	12.08	18.00
Market Cap ($ Cr)	300.97	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.01	0.12	0.16	0.13
Short term debt to equity ratio	--	0.00	0.01	0.01	0.01	0.01
Current Ratio	12.08	11.98	13.81	8.08	6.92	12.65
Quick Ratio	12.08	--	--	--	6.92	--
Interest Coverage	-976.62	-1,061.17	-99.46	-53.92	-33.16	-21.95

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	77.48	49.04	101.07	89.11	146.63	101.82
Asset Turnover	0.08	0.09	0.05	0.05	0.03	0.04
Receivable days	--	179.26	309.04	306.31	418.17	414.42
Inventory Days	--	--	--	0.00	0.00	--
Payable days	--	722.39	30.45	22.78	455.38	16.63
Cash Conversion Cycle	--	--	--	283.53	-37.21	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.